Here, we describe the generation of viable and dopamin-producing neurons derived from pluripotent mouse embryonic stem cells. Neurotrophic factors in combination with survival-promoting factors, such as interleukin-1b, glial cell line-derived neurotrophic factor, neurturin, transforming growth factor-b 3 and dibutyryl-cyclic AMP, signi®cantly enhanced Nurr1 and tyrosine hydroxylase (TH) mRNA levels, whereas En-1, mash-1 and dopamine-2-receptor mRNA levels were not upregulated. In parallel, mRNA levels of the anti-apoptotic gene bcl-2 were found to be upregulated at terminal stages. Double immuno¯uorescence analysis revealed increased numbers of TH-and dopamine transporter-, but not g-aminobutyric acid-and serotonin-positive neurons in relation to synaptophysin-labeled cells by survivalpromoting factors. Moreover, high-performance liquid chromatography analysis showed detectable levels of intracellular dopamine. We conclude that survival-promoting factors enhance differentiation, survival and maintenance of dopaminergic neurons derived from embryonic stem cells. q
Introduction
During the development of the nervous system, neural precursor cells give rise to different types of neuronal and glial cells in a regulated manner (McKay, 1989) . Previous studies on primary cultures of mouse neuroepithelial cells have shown that the proliferation of neural precursor cells in culture can be stimulated in the presence of basic ®broblast growth factor (bFGF) and epidermal growth factor (EGF; Santa-Olalla and Covarrubias, 1995; Vicario-Abejon et al., 1995) . Neural precursor cells differentiate into neurons following withdrawal of bFGF and EGF (Gritti et al., 1995) .
Because primary cultures are not suitable for studies regarding committment into the neuroectodermal lineage, embryonic stem (ES) and embryonic carcinoma (EC) celldifferentiation systems were applied. ES cells, pluripotent cell lines derived from the inner cell mass of blastocysts, are able to differentiate into the endodermal, mesodermal and ectodermal lineage (i.e. Rohwedel et al., 1994 Rohwedel et al., , 1998 Stru Èb-ing et al., 1995; Wobus et al., 1997; Drab et al., 1997; Wobus and Guan, 1998) . The same was true for embryonic germ (EG) cells derived from mouse primordial germ cells . The differentiation pattern of these pluripotent embryonal stem cells may be signi®cantly in¯u-enced by differentiation factors, such as retinoic acid (Bain et al., 1995; Fraichard et al., 1995; Stru Èbing et al., 1995) , or by serum withdrawal and treatment with neurotrophic factors (Okabe et al., 1996; Lee et al., 2000) . It was demonstrated that neural precursor cells and functional postmitotic neurons can be generated in vitro under conditions similar to those used for brain-derived cultures (Gritti et al., 1996; Lee et al., 2000) . However, until now, the long-term viability of these ES cell-generated neuronal cells has not been demonstrated.
Neurotrophic factors and cytokines promote differentiation, survival and maintenance of neurons in vitro. Previous studies using developing and adult midbrain neurons have shown that glial cell line-derived neurotrophic factor (GDNF) exerts protective effects on dopaminergic cells (Beck et al., 1995; Eggert et al., 1999;  for review see Saarma and Sariola, 1999) . Similar observations were made for neurturin (NTN), another member of the GDNF family (Horger et al., 1998; Rosenblad et al., 1999) and transforming growth factor-b 3 (TGF-b 3 ; Krieglstein et al., 1998) .
Both GDNF and NTN bind to members of a family of highaf®nity glycosylphosphatidylinositol (GPI)-anchored receptors, collectively named GDNF family receptor a (GFRa), to form a complex that subsequently activates the receptor tyrosine kinase Ret by autophosphorylation (Baloh et al., 1997; Airaksinen et al., 1999) . Therefore, the activation of the GDNF/Ret signal transduction pathway may be responsible for trophic and neuroprotective effects on dopaminergic neurons. It has also been shown that fetal mesencephalic subependymal cells incubated in the presence of interleukin-1b (IL-1b) differentiated into mature dopaminergic neurons (Ling et al., 1998) , and addition of adenosine phosphates accelerated survival of dopaminergic neurons from ventral mesencephalon cultures (Branton et al., 1998) .
In order to establish an in vitro system of functional dopaminergic neurons, these factors, called survival-promoting factors (SPF), were applied to differentiating pluripotent embryonic stem cells and were found to increase the number and viability of tyrosine hydroxylase (TH)-and dopamine transporter (DAT)-positive dopamine producing neurons.
Results

Generation of nestin-positive neural precursor cells derived from ES and EG cells
Based on earlier ®ndings of Okabe et al. (1996) , an ef®cient protocol for growth factor-mediated lineage selection of neuronal cells was used (Fig. 1) . The protocol includes: (1) formation of cells of all three primary germ layers in the EBs, (2) selective differentiation of neuroectodermal cells by growth factor removal (serum depletion), (3) proliferation and maintenance of neural precursor cells in the presence of bFGF and EGF and (4) the differentiation induction and maintenance of functional neurons and glial cells by withdrawal of bFGF/EGF, and the combined addition of neuronal differentiation and survival-promoting factors.
To assess the developmental capacity of ES and EG cells, ®rst, the development of neural presursor cells was analyzed by immuno¯uorescence studies using nestin, a speci®c antibody against the intermediate ®lament protein of neural precursor cells  Fig. 2A,B) . We found that the number of ES or EG cells differentiating in embryoid bodies (EBs) in¯uenced the ef®ciency of neuronal differentiation. The amount of 200 ES or EG cells per EB and of 30 EBs per culture dish plated at day 4 (ES cells) and 5 (EG cells), respectively, resulted in the most signi®cant increase of the number of neural precursor cells ( Fig. 2C ; data for 100 and 400 cells not shown). Four days after plating, 58% of ES cell-derived neural precursor cells were labeled by the nestin-speci®c antibody. A maximum level of 85% nestin-positive cells was found at day (d) 4 1 6, which subsequently declined to 70% (4 1 10d) and 44% (4 1 13d). The amount of nestin-positive EG cell-derived neural precursor cells increased from 66% (5 1 5d) to a maximum level of 75% (5 1 10d) and decreased to 60% at day 5 1 13.
2.2. Upregulation of tyrosine hydroxylase, Nurr1 and bcl-2 mRNA levels by survival-promoting factors (SPF)
To answer the question whether the application of survival-promoting factors (SPF, IL-1b, GDNF, TGF-b 3 , NTN, db-cAMP) affected the expression of neuron-speci®c genes, mRNA levels of genes encoding the transcription factors Engrailed-1 (En-1) and mash-1, the long isoform of dopamine receptor 2 (D 2 R-L; Montmayeur and Borrelli, 1991) , tyrosine hydroxylase (TH), and the orphan nuclear steroid receptor Nurr1 were analyzed by semi-quantitative reverse transcription±polymerase chain reaction (RT±PCR). Our data clearly indicated that survival-promoting factors increased mRNA levels of TH and Nurr1, genes speci®c for dopaminergic neurons, whereas En-1, mash-1 and D 2 R-L mRNA levels were not in¯uenced. TH mRNA levels were upregulated from 9% (4d) to 76% (4 1 12d; Fig. 3D ). The application of survival-promoting factors, beginning at day 4 1 14, resulted in a signi®cant upregulation of TH mRNA levels with 63% compared to 36% of the control variant (4 1 23d), and maximum levels were detected in SPF-treated cultures with 80% at day 4 1 30. Nurr1 mRNA levels increased from 22% at day 4 1 7 to 57% at day 4 1 12, and were signi®cantly upregulated after application of survivalpromoting factors with maximum levels of 76% at day 4 1 35 ( Fig. 3E) .
Whereas En-1 mRNA levels were found to increase from the early differentiation stage (4d) with 41 to 64% at 4 1 12d (Fig. 3B) , survival-promoting factors did not signi®cantly upregulate the mRNA levels. A maximum level of 83 vs. 60% in the control group was attained in the SPF-treated variant at day 4 1 30. Mash-1 mRNA levels revealed a similar expression pattern (data not shown). D 2 R-L mRNA levels attained values between 4% (4 1 4d) and 41% (4 1 16d), but treatment with survival-promoting factors did not affect mRNA levels compared to control variants (Fig. 3C) .
To analyze whether the survival-promoting factors in¯u-enced apoptosis-related processes in ES cell-derived neuronal cultures, mRNA levels of the gene encoding the antiapoptosis protein bcl-2 were analyzed. In the control variant, maximum bcl-2 mRNA levels of 94% (4 1 7d) were detected, which declined during the further differentiation process to 4% at day 4 1 44 ( Fig. 3F) . SPF-treated cultures revealed upregulated bcl-2 mRNA levels with signi®cant differences to the control variant of 72 vs. 30% (4 1 35d), 61 vs. 23% (4 1 40d) and 55 vs. 12% (4 1 44d), respectively.
Induction of differentiation of TH-and DAT-positive cells by SPF
To determine the in¯uence of survival-promoting factors on the differentiation of neural precursor cells into dopaminergic neurons, the amount of tyrosine hydroxylase (TH)-and dopamine transporter (DAT)-labeled neurons was analyzed. Double immuno¯uorescence analysis using antibodies against TH and DAT, respectively, counterstained against the neuronal marker synaptophysin (Syn) revealed networks of TH- (Fig. 4C ) and DAT- (Fig. 4G ) positive neuronal cells in both, control (2SPF) and SPF-treated (1SPF) cultures. However, application of survival-promoting factors between days 4 1 14 and 4 1 30 resulted in a signi®cant increase in the frequency of TH-and DAT-positive neurons calculated as percent value of Syn-labeled neurons in comparison to the control variant (Fig. 4D,H) . Maximum levels of TH-positive neurons with 43 vs. 22%, and of DAT-positive neurons with 39 vs. 20% of control variants, respectively, were found. This increase was stable until terminal differentiation stage (4 1 30d). There were no signi®cant stage-dependent variations in the levels of TH-or DAT-positive neurons within the SPF and control (2SPF) group.
To answer the question whether treatment by survivalpromoting factors also affected other neurotransmitter path- ways, immunocytochemistry using antibodies against gaminobutyric acid (GABA) as a marker for inhibitory neurons and serotonin, a transmitter found in ventral hindbrain neurons was performed. Double immuno¯uorescence analysis revealed GABA (Fig. 5A )-and serotonin ( Fig. 5C )-positive neuronal cells in both, control (2SPF) and SPFtreated cultures. Application of survival-promoting factors between days 4 1 14 and 4 1 30 did not affect the frequency of GABA-and serotonin-positive neurons calculated as percent value of Syn-labeled neurons in comparison to the control (2SPF) variant (Fig. 5B,D) . Maximum levels of GABA-positive neurons with 15.3% (1SPF) and 14.1% (2SPF), and of serotonin-positive neurons with 12.5% (1SPF) and 11.9% (2SPF), respectively, were found.
Correlation between the formation of TH-positive neurons and GFAP-positive astrocytes in ES-cell derived cultures
To analyze whether survival-promoting factors in¯uence the formation of glial cells and thereby mediate the response Fig. 3 . mRNA levels of neuronal-speci®c and apoptosis-related genes. (A) The ethidium bromide gels of semi-quantitative RT-PCR products were analyzed by computer-assisted densitometry. Data were plotted (in %) for En-1 (B), D 2 R-L (C), TH (D), Nurr1 (E) and bcl-2 (F) mRNA levels, respectively, in relation to mRNA levels of the housekeeping gene b-tubulin used as internal standard. ES cell derived cultures were treated without (2SPF) or with (1SPF) survival-promoting factors from days 4 1 14 to 4 1 44. Gels of four independent experiments were analyzed. Each column represents the mean value^SEM. Statistical signi®cance was tested by the Student t-test: *P , 0:05; **P , 0:01. to survival-promoting factors, immuno¯uorescence analyses using an antibody against the astrocytic marker glial ®brillary acidic protein (GFAP) were carried out. GFAP-positive cells were identi®ed in SPF-treated and control groups and increased in number from day 4 1 16 to 4 1 23 and 4 1 30. Glial cells were detected in cell clusters of low density at the early differentiation stage and revealed high densities at terminal stages (Fig. 6A,C) . GFAP-positive astrocytes formed layers in close contact to TH-positive neurons. However, there were no quantitative differences in the number of GFAP-labeled cells between SPF-treated and control groups.
To answer the question whether ES cell-derived dopaminergic neurons are sensitive to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a toxin which selectively destroys dopaminergic neurons, double immuno¯uorescence analysis was performed. In cultures treated with MPTP at an early differentiation stage (4 1 16 to 4 1 18d), TH-positive neurons were identi®ed with a similar morphology compared to untreated cultures, and cell clusters with only a low density of GFAP-positive astrocytes were found (Fig. 6A,B) . In contrast, addition of MPTP at a late differentiation stage (4 1 30 to 4 1 32d) caused cell shrinkage and destroyed the neuronal network of TH-labeled neurons, whereas synaptophysin-labeled neurons were not affected in the same manner (not shown). GFAP-positive astrocytes were prominent in high densities in both, MPTP-treated and untreated control variants (Fig. 6C,D) , demonstrating that dopaminergic neurons generated from ES cells revealed a functional response to MPTP dependent on the development of glial cells.
Survival-promoting factors stimulate dopamine synthesis
As the production of dopamine is a de®nitive identi®ca-tion of a dopaminergic neuron, high-performance liquid chromatography (HPLC) was used to measure intracellular dopamine in ES cell-derived neurons (Fig. 7) . Preliminary data suggest that application of survival-promoting factors resulted in higher amounts of dopamine (range 0.76±0.98 pmol/5 £ 10 6 cells) compared to untreated controls (range 0±0.45 pmol/5 £ 10 6 cells).
Discussion
We found that the addition of survival-promoting factors IL-1b, GDNF, NTN, TGF-b 3 and db-cAMP during terminal differentiation stages signi®cantly enhanced the differentiation and viability of ES cell-derived dopaminergic neurons. This was demonstrated at the level of gene expression and by immunocytochemical properties. SPF upregulated mRNA levels of TH, Nurr1 and bcl-2 genes leading to a signi®cant increase of TH-and DAT-positive neurons at terminal stages, whereas GABAergic and serotoninergic neurons were not increased. Additionally, intracellular dopamine levels were stimulated by SPFs.
In agreement with previous ®ndings (Okabe et al., 1996) , in our study, 85% of ES cell-derived cells were nestin-positive neural precursor cells. To answer the question, whether neural precursor cells can also be generated from EG cells, the same differentiation protocol was used and found to result in a similar high percentage of nestin-positive neural precursor cells.
According to Suter-Crazzolara and Unsicker (1996) , the proliferation-inducing effect of bFGF may be in part mediated by endogenous GDNF. In a glioblastoma cell line bFGF upregulated GDNF mRNA levels, and both bFGF and endogenous GDNF stimulated proliferation of neural precursor cells. The further decrease in the number of nestin-positive cells observed in our experiments might be explained by increased neuro-and gliogenesis , which is paralleled by nestin downregulation, whereas new cell type-speci®c proteins, such as synaptophysin and GFAP, are upregulated. The differentiation induction of TH-positive neurons was shown by treatment of differentiating ES cells with FGF8, sonic hedgehog and ascorbic acid (Lee et al., 2000) , but no evidence for long-term viability and survival of dopaminergic neurons at terminal differentiation stages was presented.
As revealed by our studies, the application of survivalpromoting factors in combination with neurotrophic factors to differentiating ES cell-derived neural cells in¯uenced the expression of neuronal genes. Whereas En-1, mash-1 and D 2 R-L mRNA levels were not signi®cantly in¯uenced, Nurr1 mRNA levels were signi®cantly upregulated at terminal stages. While TH mRNA levels progressively increased during application of survival-promoting factors, the increase was delayed and less pronounced within the control group. Nurr1 is an orphan receptor belonging to the thyroid hormone/retinoic acid nuclear receptor superfamily (Law et al., 1992) . It is expressed at embryonic day 10.5 in the ventral aspect of the mesencephalic¯exure just prior to the appearance of TH, the rate-limiting enzyme for the biosynthesis of dopamine, at day 11.5, and is continuously expressed into adulthood (Kaufman, 1995; Zetterstro Èm et al., 1996; Haavik and Toska, 1998) . Nurr1 is speci®cally required for the induction of midbrain neuronal precursor cells to adopt the dopaminergic phenotype, because it activates the transcription of TH by binding a response element within a region of the TH promoter (Saucedo-Cardenas et al., 1998; Sakurada et al., 1999; Wagner et al., 1999) . Therefore, one might conclude that survival-promoting factors (i) support the differentiation of neural precursor cells into dopaminergic neurons and (ii) maintain the long-term increase of dopaminergic neurons by promoting the induction of TH-synthesis via upregulation of the region-speci®c transcription factor Nurr1.
D 2 R-L, the more prevalent form of the dopamine-2 receptor, is found in different brain regions including the substantia nigra, cerebral cortex, striatum and the limbic system (Weiner et al., 1991) . Dopaminergic neurons contain autoreceptors which regulate either electrical ®ring of these cells in the substantia nigra or TH activity on the nerve terminals within the striatum (for review see Kebabian and Calne, 1979) . Because D 2 R-L mRNA levels were not affected, the D 2 R seems not to be a target of survival-promoting factors.
The upregulated bcl-2 mRNA levels after application of survival-promoting factors suggested an anti-apoptotic effect of those compounds. The integral membrane protein bcl-2 protects cells from apoptotic cell death (Merry and Korsmeyer, 1997) . In our study, bcl-2 mRNA levels attained maximum values at early differentiation stages. In SPFuntreated control variants, bcl-2 mRNA levels decreased during further differentiation. These ®ndings are supported by in vivo analyses, where bcl-2 mRNA is maximally expressed during embryonic development, but postnatally, mRNA levels continuously decline (Castren et al., 1994) . The upregulation of bcl-2 mRNA at terminal stages observed in our experiments may be caused by TGF-b 3 , because previous studies on hippocampal neurons have shown that TGF-bs induced expression of bcl-2 (Flanders et al., 1998) .
It seems likely that also cAMP revealed an anti-apoptotic effect, because the application of cAMP probably maintains phosphorylation and therefore reactivation of protein kinase B to prevent apoptosis (Branton et al., 1998) . Whereas the addition of survival-promoting factors did not affect the population of astrocytes in our cultures, other authors found that cAMP inhibited proliferation, but induced the differentiation of astrocytes (Michel et al., 1999) .
IL-1b signi®cantly increased the amount of TH-positive neurons as early as 2 days after application. Because it has previously been shown that IL-1b plays a central role in the conversion of mesencephalic-derived progenitors to dopaminergic neurons (Potter et al., 1999) , this seems to be true also for ES cell-generated neurons. IL-1b may induce the expression of speci®c receptors, which allow the progenitors to become responsive to additional factors present in the media, probably by gp130-linked or Ret receptors, which increase the response to GDNF.
The mechanisms by which IL-1b, GDNF, NTN and TGFb 3 induce and maintain dopaminergic neurons resulting in anti-apoptotic processes are not fully understood, but may be similar to those observed in primary cultures: neuritogenic, hypertrophic and survival-promoting activities, common stabilization and/or recruitment of GFRa Krieglstein et al., 1998) .
Data suggesting a functional capacity of ES cell-derived TH-positive neurons were provided by measuring intracellular dopamine by HPLC. Consistent with the increase in the number of TH-positive neurons, the dopamine levels were elevated in cultures treated with survival-promoting factors. As data presented here are preliminary, future experiments will include measurements of dopamine release after depolarization. Quantitative HPLC analyses, investigating other neurotransmitters and their metabolites, will extend these functionally-related biochemical data and further characterize the effects of survival-promoting factors.
The signi®cant loss of TH-positive neurons after incubation with MPTP obviously demonstrated that (i) GFAPpositive astrocytes revealed monoamine oxidase B activity, because MPTP has to be converted to its toxic metabolite MPP 1 for neurotoxic effects (Heikkila et al., 1984; Javitch et al., 1985) , and (ii) DAT is functionally active, because speci®c catecholamine uptake sites on terminals and cell bodies of dopaminergic neurons accumulate MPP 1 (for review see Przedborski and Jackson-Lewis, 1998) . Our data are in agreement with observations of cerebellar granule cells (Marini et al., 1989) and con®rmed earlier ®nd-ings in cultured mesencephalic dopaminergic neurons (Hyman et al., 1991) . The enhanced MPTP effect at late differentiation stages may be due to an increased number of astrocytes.
In conclusion, the ES cell differentiation protocol presented here will be useful in further studies aimed at the generation of viable dopaminergic neurons in culture. The system may be used in pharmacological assays to analyze the activity of medical drugs for treatment of Parkinson's disease, or to identify the effects of toxic factors to dopaminergic neurons by in vitro analyses. The system may also be helpful in high-throughput screening assays using cDNA microarrays to identify regulatory genes and mechanisms involved in the differentiation of dopaminergic neurons. Finally, by survival-promoting factors it will be possible to enhance the maintenance and viability of human ES (Thomson et al., 1998) or EG (Shamblott et al., 1998) cell-derived neuronal cells to be used as cellular grafts for the treatment of Parkinson's disease.
Materials and methods
ES cell culture and differentiation
ES cells of line R1 (Nagy et al., 1993) and EG cells of line EG-1 (Stewart et al., 1994) were grown on a feeder layer of primary mouse embryonic ®broblasts in Dulbecco's modi®ed Eagle's medium (DMEM; Gibco BRL, Life Technologies, Eggenstein, Germany) supplemented by 10 ng/ml recombinant human leukemia inhibitory factor (LIF; for preparation see Fa Èssler et al., 1996) , 15% heat-inactivated fetal calf serum (FCS), 2 mM l-glutamine, non-essential amino acids (NEAA; stock solution diluted 1:100; all from Gibco) and 5 £ 10 25 M b-mercaptoethanol (Serva, Heidelberg, Germany) as described (Wobus et al., 1991 .
The ES cell differentiation protocol is shown in Fig. 1 . For differentiation of neural phenotypes, ES or EG cells were cultivated in`hanging drops' (n 100, 200 or 400 cells/drop) as aggregates called`embryoid bodies' (EBs) for 2 days. EBs were transferred to bacteriological petri dishes (Greiner, Germany) and cultivated for 2 days in Iscove's modi®cation of DMEM (IMDM; Gibco) containing 20% FCS and supplements as described (Rohwedel et al., 1998) , with the exception that b-mercaptoethanol was replaced by 450 mM a-monothioglycerol (Sigma, Steinheim, Germany). EBs (n 20±30) were plated onto tissue culture dishes (diameter 6 cm) at day 4 (ES cells) or day 5 (EG cells) and cultivated in IMDM 1 20% FCS. The selection of neural precursor cells was carried out according to Okabe et al., 1996 with some minor modi®cations. After attachment of EBs, 1 day later, the medium was exchanged by DMEM/F12 medium supplemented with 5 mg/ml insulin, 30 nM sodium selenite (both from Sigma), 50 mg/ml transferrin and 5 mg/ml ®bronectin (both from Gibco). The culture medium was replenished every 2 days. Nestin-positive neural precursor cells were selected after cultivation for 7 days ( 4 1 7d). At day 4 1 8, EBs were dissociated by 0.1% trypsin (Gibco)/0.08% EDTA (Sigma) in phosphatebufferd saline (PBS) (1:1) for 1 min, collected by centrifugation, and replated onto poly-l-ornithine/laminin-coated tissue culture dishes into DMEM/F12 containing 20 nM progesterone, 100 mM putrescine, 1 mg/ml laminin (all from Sigma), 25 mg/ml insulin, 50 mg/ml transferrin and 30 nM sodium selenite for 6 days until day 4 1 13. The medium was changed every 2 days. Basic ®broblast growth factor (bFGF, 10 ng/ml) and epidermal growth factor (EGF; 20 ng/ml; Strathmann Biotech, Hannover, Germany) were added daily. At day 4 1 14, the differentiation of mature neurons was induced by`Neurobasal' medium plus 2% B27 (Gibco), 10% FCS and the survival-promoting factors: interleukin-1b (IL-1b, 200 pg/ml; PeproTech, London, UK) was added daily and db-cAMP (700 mmol; Sigma) at every 4 days beginning at day 4 1 14. Glial cell line-derived neurotrophic factor (GDNF, 2 ng/ml; R&D Systems) and transforming growth factor-b 3 (TGF-b 3 , 2 ng/ml) were applied beginning at day 4 1 18 and at day 4 1 21, respectively. Neurturin (NTN, 10 ng/ml; all from PeproTech) was applied beginning at day 4 1 21. The application of survival-promoting factors during terminal stages was combined with medium changes at three-day intervals.
4.2. Detection of En-1, mash-1, D 2 R-L, TH, Nurr1 and bcl-2 mRNA levels by semi-quantitative RT-PCR analysis ES cells, EBs or differentiated cells collected at days 4, 4 1 4, 4 1 7, 4 1 12, 4 1 16, 4 1 23, 4 1 30, 4 1 35, 4 1 40 and 4 1 44 were suspended in lysis buffer (4 M guanidinium thiocyanate, 25 mM sodium citrate, pH 7; 0.5% sarcosyl, 1% b-mercaptoethanol). Total RNA was isolated by the single step extraction method according to Chomczynski and Sacchi (1987) . RNA was reverse transcribed using Oligo d(T) 16 primers (Perkin-Elmer, U È berlingen, Germany) and ampli®ed using oligonucleotide primers speci®c for the following genes (oligonucleotide sequences are given in brackets in the order sense-, antisense-primer followed by the annealing temperature used for PCR, the length of the ampli®ed fragments in base pairs and the reference): En- Wang et al., 1986) . Reverse transcription was performed with MuLV reverse transcriptase (Perkin Elmer) for 1 h at 428C, followed by denaturation for 5 min at 998C and cooling to 48C according to the protocol supplied by the manufacturer. For semi-quantitative determination of mRNA levels, PCR analyses were carried out with Ampli Taq DNA polymerase (Perkin Elmer). For determination of relative mRNA levels, two separate PCR reactions, either using primers of the analyzed gene or primers speci®c for b-tubulin were performed with 3 ml from each RT reaction, and 39 (En-1), 40 (mash-1), 45 (D 2 R-L), 35 (TH), 38 (Nurr1), 35 (bcl-2) and 28 cycles (b-tubulin), respectively, were used.
One third of each PCR reaction was electrophoretically separated on 2% agarose gels containing 0.35 mg/ml ethidium bromide. Gels were illuminated with UV light and the ethidium bromide¯uorescence signals were stored by the E.A.S.Y. system (Herolab, Wiesloch, Germany) and analyzed by the TINA2.08e software (Raytest Isotopen-meûgera Ète, Straubenhardt, Germany). Data of the target genes were plotted as percentage changes in relation to the expression of the housekeeping gene b-tubulin. Gels of four independent experiments were analyzed.
Immuno¯uorescence analysis
Indirect immuno¯uorescence analysis was carried out at days 4 1 4, 4 1 6, 4 1 10, 4 1 13, 4 1 16, 4 1 23, 4 1 30 and 4 1 32. Cells cultivated on coverslips were rinsed with PBS and ®xed for 20 min with PBS containing 4% paraformaldehyde at room temperature. Preparations were incubated with 1% bovine serum albumine in PBS for 30 min followed by incubation with the primary antibodies at 378C in a humidi®ed chamber for 1 h. The following antibodies were analyzed: nestin (1:2; Developmental Studies Hybridoma Bank, Iowa, USA), the synaptic vesicle protein synaptophysin (Syn, 1:4; Calbiochem, Schwalbach, Germany), tyrosine hydroxylase (TH, 1:250), dopamine transporter (DAT, 1:250; both from Chemicon, Hofheim, Germany), g-aminobutyric acid (GABA, 1:1000), serotonin (Ser, 1:4000; both from Sigma), and glial ®brillary acidic protein (GFAP, 1:20; Roche Molecular Biochemicals, Mannheim, Germany), respectively. After washing (three times) with PBS, cells were incubated for 1 h at 378C with¯uores-cence-labeled secondary antibodies which were either anti-mouse IgG-Cy 3 (1:800, Jackson Immuno Research) or anti-rabbit IgG-FITC (1:100), rinsed (three times) with PBS and with A. tridest. (once). After being embedded in Vectashield mounting medium (Vector, USA), specimens were analyzed with the¯uorescence microscope (Nikon, Germany) or the confocal laser scanning microscope (CLSM 410, Carl Zeiss, Jena, Germany). The quantitative estimation based on the evaluation of immunopositive areas either labeled with the anti-nestin antibody in comparison to the whole cell population, or with the anti-Syn antibody ( 100%) compared to TH-, DAT-, GABA-and Ser-positive areas: Each coverslip was divided into four parts, ®ve ®elds were randomly selected, and the immunopositive areas were estimated. For each value, two coverslips of four independent experiments were analyzed.
For statistical evaluation, experimental groups were compared using analysis of variance (ANOVA) followed by the Student t-test (Instat 2 statistic software).
Determination of dopamine by HPLC
Dopamine was measured in ES cell-derived preparations using HPLC with electrochemical detection. In brief, two groups of samples were cultured in serum-free medium from day 4 1 21 to 4 1 23 and treated with (1SPF) or without (2SPF, control) survival-promoting factors according to the protocol. 4 £ 10 6 cells/preparation were collected, washed in cold buffer, centrifuged, and cold 1 N perchloric acid (PCA; Merck) with antioxidants (0.2 g/l Na 2 S 2 O 5 , 0.05 g/l Na 2 -EDTA) was added (200 ml/sample). Subsequently, samples were sonicated and centrifuged at 15 000 rev./min for 20 min at 48C. The supernatant was collected and 50 ml used for HPLC analysis. Samples were injected by means of an autosampler (Merck±Hitachi), and separation was achieved by a Waters Spherisorb S5 ODS2 guard column (4:6 £ 30 mm) and a Waters Spherisorb S3 ODS2 cartridge analytical column (4:6 £ 150 mm). The¯ow rate of the mobile phase (0.1M sodium acetate (Sigma), 6% methanol (Merck), 18 mg/ml n-octyl sodium sulfate (Merck), 13 mg/ ml EDTA (Sigma) dissolved in Milli-Q-water and adjusted to pH 4.1 with glacial acetic acid (Merck)), which was degassed with helium for 1 h before use, was adjusted to 0.9 ml/min. The electrochemical detector with inbuild column oven (Decade, Antec, Leiden, The Netherlands) was set at an oxidation potential of 10.75 V against an Ag/AgCl reference electrode. A mixture of dopamine and dopamine metabolites was used as external standards. To test the speci®c toxicity of MPTP (Sigma) to dopaminergic neurons, cultures were incubated with 100 mM of MPTP for 48 h beginning at days 4 1 16 and 4 1 30, and immuno¯uorescence analyses using antibodies against Syn, TH and GFAP were carried out. These analyses were performed on cultures without treatment by SPF, because the addition of TGF-b and GDNF was found to be neuroprotective against MPTP toxicity (Krieglstein et al., 1995; Tomac et al., 1995) .
